Fig. 6From: Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman diseaseOxysterol—Cholestane-3β,5α,6β-triol (C-triol) levels overtime per patient 1–5. Demonstrates improvement in inflammation/C-triols after HCT. The purple arrow highlights the start of ERT, the red arrow highlights the timing of HCT, blue arrows the use of bortezomib and the green arrows rituximabBack to article page